Stryker Corporation SYK

272.36 2.61 0.97% as of 25 Sep
Market cap
$103.9B
P/E
28.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Stryker Corporation (SYK) P/E ratio

As of 25 September 2026, Stryker Corporation (SYK) trades at a P/E ratio of 28.0×. Over the past ten years it has ranged from 16.1× (January 2019) to 71.2× (April 2021); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 41.4× (9.74%)
FY2024 45.9× 29.13%
FY2023 35.5× (10.06%)
FY2022 39.5× (21.88%)
FY2021 50.6× (11.91%)
FY2020 57.4× 52.25%
FY2019 37.7× 128.19%
FY2018 16.5× (71.44%)
FY2017 57.8× 113.57%
FY2016 27.1× 11.31%

Quarterly

Period P/E ratio Change
Jun 2026 32.4× (14.03%)
Mar 2026 37.6× (9.08%)
Dec 2025 41.4× (13.66%)
Sep 2025 47.9× (7.41%)
42 more quarters

Against its own ten years

Low 16.1× High 71.2×
Ten-year median 40.0×
Current reading's percentile 18

P/E ratio against peers

Company P/E ratio
GEHC GE HealthCare Technologies Inc. compare 15.3×
BSX Boston Scientific Corporation compare 17.7×
PHG Koninklijke Philips N.V. compare 18.2×
MDT Medtronic PLC compare 21.7×
STE STERIS plc compare 25.4×
SYK Stryker Corporation 28.0×
ABT Abbott Laboratories compare 32.8×
DXCM DexCom, Inc. compare 33.4×
EW Edwards Lifesciences Corporation compare 49.6×
Medical Devices industry median 22.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on SYK